IP Library › Granted Patent US 7,670,603
Granted Patent B2
US 7,670,603 · App. 12/100,088 · Granted Mar 2, 2010

Human DNAX toll-like receptor 4 proteins, related reagents and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,670,603
App. No.
12/100,088
Granted
Mar 2, 2010
Kind
B2
Abstract

Nucleic acids encoding mammalian Toll-like receptors (TLRs) have been identified in human cells. Recombinantly produced TLRs are used in the preparation of antibodies that are capable of binding to the TLRs. The antibodies are advantageously used in the prevention and treatment of septic shock, inflammatory conditions, and viral infections.

Claims (3)

1. A method of treating a patient having sepsis or septic shock, comprising administering to said patient an antibody or an antigen-binding fragment thereof that specifically binds to an isolated or recombinant polypeptide comprising the amino acid sequence of SEQ ID NO: 8.

2. The method of claim 1 , wherein said antibody or antigen-binding fragment is administered intravenously.

3. The method of claim 1 , wherein said antibody or antigen-binding fragment is administered subcutaneously.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →